National Bank of Canada’s Filana Therapeutics FLNA Stock Holding History

National Bank of Canada’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-410	Closed	-$61.5K	–	3196
2025 Q1	$61.5K	Buy	410 +227	+124%	+$573	﹤0.01%	1821
2024 Q4	$43.2K	Sell	183 -1,067	-85%	-$18.7K	﹤0.01%	1987
2024 Q3	$3.68M	Buy	+1,250	New	+$28.8K	﹤0.01%	897
2024 Q2	–	Sell	-2,800	Closed	-$5.66M	–	2816
2024 Q1	$5.66M	Buy	2,800 +2,772	+9,900%	+$63.9K	0.01%	776
2023 Q4	$62.8K	Sell	28 -1,972	-99%	-$41.7K	﹤0.01%	1697
2023 Q3	$3.36M	Buy	+2,000	New	+$39.6K	0.01%	917
2023 Q1	–	Sell	-967	Closed	-$2.86M	–	2838
2022 Q4	$2.86M	Buy	+967	New	+$34.8K	0.01%	786
2022 Q3	–	Sell	-1,377	Closed	-$3.87M	–	2863
2022 Q2	$3.87M	Buy	+1,377	New	+$34.8K	0.02%	619

Other funds holding FLNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MOS

MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

National Bank of Canada's FLNA Position: Q2 2026 in Review

National Bank of Canada reduced its Filana Therapeutics (FLNA) stake by 12% in Q2 2026, selling an estimated $285 and leaving 1,510 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

National Bank of Canada first reported a position in FLNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.4M in Q4 2021. 41 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

National Bank of Canada held 1,510 shares of Filana Therapeutics worth $1.8K as of Q2 2026.
National Bank of Canada sold 200 Filana Therapeutics shares in Q2 2026, an estimated $285.
Filana Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2718 holding.
National Bank of Canada first reported a position in Filana Therapeutics in Q4 2021 and has held it in 19 quarters since.
National Bank of Canada's Filana Therapeutics position peaked at $8.4M in Q4 2021.
41 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.